Skip to main navigation Skip to search Skip to main content

Complete Heart Block and Myocarditis Related to Immune Checkpoint Inhibitor Therapy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This is a case with metastatic melanoma on combination ipilimumab and nivolumab complicated by developing severe fulminant myocarditis. Patient presented with complete heart block requiring temporary pacemaker insertion that reversed with combination treatment of high dose steroids and abatacept. Patient remained in stable condition with normal LVEF after steroid taper without requirement of permanent pacemaker. Following the steroid taper, patient was started on the next line of therapy for melanoma which included BRAF inhibitors. He has had a durable cancer response but it is unclear whether it is due to early initiation of his next line of melanoma therapy or a lasting response from initiation 2 doses of immunotherapy.

Original languageEnglish (US)
Title of host publicationChallenging Cases in Immunotherapy Related Organ Toxicities
PublisherSpringer Science+Business Media
Pages3-8
Number of pages6
ISBN (Electronic)9783031835339
ISBN (Print)9783031835322
DOIs
StatePublished - Jan 1 2025

Keywords

  • Complete heart block
  • Immune checkpoint inhibitors
  • Myocarditis
  • Pacemaker
  • Toxicity

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Complete Heart Block and Myocarditis Related to Immune Checkpoint Inhibitor Therapy'. Together they form a unique fingerprint.

Cite this